Leadership
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Gender Diversity In Pharma: Caught Between Desire And Reality
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
Latest From Leadership
Creating Stability In A Time Of Transition
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.
Execs On The Move, February 2020
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Investing In People: Aligning VCs And Today’s Entrepreneurs
In the latest instalment of our VC playbook series, In Vivo sits down with Roel Bulthuis, managing partner at INKEF Capital, to discuss the group’s approach to health care investing in Europe, the importance of funding a team not just a project and how life sciences venture capital is evolving with the emergence of health tech.
C-Suite Snippets: US Generics Industry Under Pressure
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.
Execs On The Move, January 2020
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
What Does 2020 Hold For Biopharma?
Previewing the year to come, our journalists contacted more than 80 industry executives and experts for their views on what 2020 could hold for the biopharma sector. A series of articles based on these discussions were published by In Vivo’s sister publication Scrip. The following are highlights of the key issues that are top of mind for industry leaders this year, including digital tools, advanced therapies, the US election and manufacturing.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.